Rohit Aggarwal

12.9k total citations · 3 hit papers
168 papers, 5.3k citations indexed

About

Rohit Aggarwal is a scholar working on Epidemiology, Rheumatology and Immunology. According to data from OpenAlex, Rohit Aggarwal has authored 168 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Epidemiology, 65 papers in Rheumatology and 30 papers in Immunology. Recurrent topics in Rohit Aggarwal's work include Inflammatory Myopathies and Dermatomyositis (116 papers), Eosinophilic Disorders and Syndromes (39 papers) and Muscle Physiology and Disorders (23 papers). Rohit Aggarwal is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (116 papers), Eosinophilic Disorders and Syndromes (39 papers) and Muscle Physiology and Disorders (23 papers). Rohit Aggarwal collaborates with scholars based in United States, India and United Kingdom. Rohit Aggarwal's co-authors include Chester V. Oddis, Siamak Moghadam‐Kia, Diane Koontz, Dinesh Khanna, Frederick W. Miller, Noreen Fertig, Raj Nair, Brian M. Feldman, Marc C. Levesque and Lisa Christopher‐Stine and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Rohit Aggarwal

155 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

2012 448 citations Chester V. Oddis, Rohit Aggarwal et al. profile →
Idiopathic inflammatory myopathies

2021 347 citations Ingrid E. Lundberg, Jiří Vencovský et al. profile →
Distinctions Between Diagnostic and Classification Criteria?

2015 299 citations Rohit Aggarwal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rohit Aggarwal United States	36	3.1k	2.1k	996	790	781	168	5.3k
Albert Selva-O’Callaghan Spain	37	2.9k 0.9×	2.4k 1.1×	694 0.7×	971 1.2×	826 1.1×	188	5.3k
Lorenzo Dagna Italy	42	1.2k 0.4×	1.9k 0.9×	1.6k 1.6×	609 0.8×	1.1k 1.4×	300	7.0k
Pilar Brito‐Zerón Spain	47	1.4k 0.5×	3.3k 1.5×	1.9k 1.9×	909 1.2×	716 0.9×	120	8.8k
Florenzo Iannone Italy	42	929 0.3×	3.3k 1.5×	1.4k 1.4×	688 0.9×	1.0k 1.3×	349	6.8k
Marta Mosca Italy	46	1.4k 0.5×	4.4k 2.1×	2.5k 2.5×	1.6k 2.0×	614 0.8×	311	7.7k
Eun Bong Lee South Korea	39	959 0.3×	3.9k 1.8×	1.8k 1.8×	769 1.0×	980 1.3×	242	7.2k
James Galloway United Kingdom	37	802 0.3×	2.7k 1.3×	986 1.0×	571 0.7×	322 0.4×	278	5.5k
Wen Zhang China	37	989 0.3×	2.0k 0.9×	746 0.7×	417 0.5×	834 1.1×	245	5.4k
Sindhu R. Johnson Canada	44	667 0.2×	1.9k 0.9×	1.2k 1.2×	1.9k 2.4×	358 0.5×	156	5.5k
M.‐A. Richard France	40	1.1k 0.3×	749 0.3×	1.6k 1.6×	530 0.7×	622 0.8×	204	5.0k

Countries citing papers authored by Rohit Aggarwal

Since Specialization

Citations

This map shows the geographic impact of Rohit Aggarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Aggarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Aggarwal more than expected).

Fields of papers citing papers by Rohit Aggarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohit Aggarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Aggarwal. The network helps show where Rohit Aggarwal may publish in the future.

Co-authorship network of co-authors of Rohit Aggarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Rohit Aggarwal. A scholar is included among the top collaborators of Rohit Aggarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohit Aggarwal. Rohit Aggarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aggarwal, Rohit, Joachim Schessl, Zsuzsanna Bata‐Csörgõ, et al.. (2025). Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatology and Therapy. 12(5). 855–871.

Moghadam‐Kia, Siamak, et al.. (2025). Fatigue is common in myositis and is associated with disease activity. Seminars in Arthritis and Rheumatism. 73. 152730–152730.

Aggarwal, Rohit, Siamak Moghadam‐Kia, Sangmee Bae, et al.. (2025). Abatacept for the treatment of myositis-associated interstitial lung disease. Lara D. Veeken. 64(SI). SI156–SI168. 2 indexed citations

Xenakis, Jason, et al.. (2024). Cutaneous Manifestations in Patients with Dermatomyositis, Are They Only Skin Deep?. Dermatology and Therapy. 14(10). 2771–2785. 2 indexed citations

Bae, Sangmee, Fereidoun Abtin, Grace Kim, et al.. (2024). Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease. RMD Open. 10(4). e004592–e004592.

Christopher‐Stine, Lisa, Hector Chinoy, Namita Goyal, et al.. (2024). The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms. The Journal of Rheumatology. 51(12). 1198–1207. 1 indexed citations

Santos, C. Sieiro, Elena Nikiphorou, Chih‐Wei Tseng, et al.. (2024). Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study. Rheumatology International. 44(5). 805–817. 2 indexed citations

Aggarwal, Rohit, et al.. (2024). Features of Swallowing Function in Sporadic Inclusion Body Myositis: Preliminary Evidence Using Well-Tested Assessment Frameworks. American Journal of Speech-Language Pathology. 33(6). 2793–2804.

Saygın, Didem, Matteo Bottai, Marjolein Visser, et al.. (2023). Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clinical and Experimental Rheumatology. 42(2). 403–412. 4 indexed citations

10.

Joshi, Mrudula, R Naveen, Vikas Agarwal, et al.. (2023). Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis. Clinical Rheumatology. 42(5). 1339–1349. 10 indexed citations

11.

Sen, Parikshit, R Naveen, Arvind Nune, et al.. (2023). Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study. The Lancet Rheumatology. 5(5). e247–e250. 6 indexed citations

12.

Chatterjee, Tulika, R Naveen, Abraham Edgar Gracia‐Ramos, et al.. (2023). Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study. Journal of Diabetes Investigation. 15(1). 131–138.

13.

Padilla, Cristina Rodríguez, et al.. (2022). Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report. Clinical Rheumatology. 41(5). 1597–1601. 18 indexed citations

14.

Pakhchanian, Haig, Hiba Khan, Rahul Raiker, et al.. (2022). COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis. Seminars in Arthritis and Rheumatism. 56. 152034–152034. 8 indexed citations

15.

Saygın, Didem, Bonny Rockette‐Wagner, Chester V. Oddis, et al.. (2021). Consumer-based activity trackers in evaluation of physical activity in myositis patients. Lara D. Veeken. 61(7). 2951–2958. 17 indexed citations

16.

Rockette‐Wagner, Bonny, Didem Saygın, Siamak Moghadam‐Kia, et al.. (2021). Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Lara D. Veeken. 60(12). 5713–5723. 23 indexed citations

17.

Naveen, R, et al.. (2021). COVID-19 and Myositis: What We Know So Far. Current Rheumatology Reports. 23(8). 63–63. 85 indexed citations

18.

Oldroyd, Alexander, Jeffrey P. Callen, Hector Chinoy, et al.. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Lara D. Veeken. 60(11). 5483–5483. 4 indexed citations

19.

Saygın, Didem, Chester V. Oddis, Galina Marder, et al.. (2020). Follow-up results of myositis patients treated with H. P. Acthar gel. Lara D. Veeken. 59(10). 2976–2981. 8 indexed citations

20.

Saygın, Didem, Chester V. Oddis, Siamak Moghadam‐Kia, et al.. (2020). Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies. Lara D. Veeken. 60(5). 2146–2156. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact